AngioDynamics to Present at RBC Capital Markets 2006 Healthcare Conference

December 6, 2006 at 12:00 AM EST
AngioDynamics to Present at RBC Capital Markets 2006 Healthcare ConferenceQUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 6, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that its president and chief executive officer, Eamonn P. Hobbs, will participate in a panel entitled: "Away From the Heart: Expanding the Role of Interventional Medicine," at the upcoming RBC Capital Markets 2006 Healthcare Conference. The panel is scheduled for 12:30 PM (Eastern Time) on Wednesday, December 13, 2006. The event will be held from December 13-14, 2006 at the Westin Times Square Hotel in New York.

Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of AngioDynamics' web site, www.angiodynamics.com a few minutes prior to start time to download any necessary software. The presentation will be archived for 30 days.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products. More information is available at www.angiodynamics.com.



CONTACT: Company Contacts:


AngioDynamics, Inc.
Joe Gerardi, 800-772-6446 x115
http://www.angiodynamics.com/
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.


Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com



SOURCE: AngioDynamics, Inc.